Lupin LimitedNSE: LUPIN

Press Release Feb 16 2024

· Issued by Lupin Limited

Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated February 16, 2024, titled "Lupin Receives Approval from U.S. FDA for MinzoyaTM (Levonorgestrel and EthinylEstradiol Tablets, USP and Ferrous Bisglycinate Tablets).".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases